Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2047569rdf:typepubmed:Citationlld:pubmed
pubmed-article:2047569lifeskim:mentionsumls-concept:C0023418lld:lifeskim
pubmed-article:2047569lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:2047569lifeskim:mentionsumls-concept:C0596402lld:lifeskim
pubmed-article:2047569lifeskim:mentionsumls-concept:C0013089lld:lifeskim
pubmed-article:2047569lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2047569lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:2047569lifeskim:mentionsumls-concept:C0055082lld:lifeskim
pubmed-article:2047569lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:2047569lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:2047569pubmed:issue2lld:pubmed
pubmed-article:2047569pubmed:dateCreated1991-7-18lld:pubmed
pubmed-article:2047569pubmed:abstractTextThe effect of cepharanthine on the cytotoxicity of doxorubicin (DOX) in p388 leukemia cells was studied in vitro and in vivo. Nontoxic levels of cepharanthine enhanced the sensitivity to doxorubicin in p388 cells in vitro. The potentiation of antitumor activity of DOX by cepharanthine against mice bearing p388 cells was also observed.lld:pubmed
pubmed-article:2047569pubmed:languageenglld:pubmed
pubmed-article:2047569pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2047569pubmed:citationSubsetIMlld:pubmed
pubmed-article:2047569pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2047569pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2047569pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2047569pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2047569pubmed:statusMEDLINElld:pubmed
pubmed-article:2047569pubmed:monthFeblld:pubmed
pubmed-article:2047569pubmed:issn0034-5164lld:pubmed
pubmed-article:2047569pubmed:authorpubmed-author:SasakiKKlld:pubmed
pubmed-article:2047569pubmed:authorpubmed-author:KawauchiHHlld:pubmed
pubmed-article:2047569pubmed:authorpubmed-author:FurusawaSSlld:pubmed
pubmed-article:2047569pubmed:authorpubmed-author:FujimuraTTlld:pubmed
pubmed-article:2047569pubmed:authorpubmed-author:TakayanagiYYlld:pubmed
pubmed-article:2047569pubmed:issnTypePrintlld:pubmed
pubmed-article:2047569pubmed:volume71lld:pubmed
pubmed-article:2047569pubmed:ownerNLMlld:pubmed
pubmed-article:2047569pubmed:authorsCompleteYlld:pubmed
pubmed-article:2047569pubmed:pagination235-8lld:pubmed
pubmed-article:2047569pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:2047569pubmed:meshHeadingpubmed-meshheading:2047569-...lld:pubmed
pubmed-article:2047569pubmed:meshHeadingpubmed-meshheading:2047569-...lld:pubmed
pubmed-article:2047569pubmed:meshHeadingpubmed-meshheading:2047569-...lld:pubmed
pubmed-article:2047569pubmed:meshHeadingpubmed-meshheading:2047569-...lld:pubmed
pubmed-article:2047569pubmed:meshHeadingpubmed-meshheading:2047569-...lld:pubmed
pubmed-article:2047569pubmed:meshHeadingpubmed-meshheading:2047569-...lld:pubmed
pubmed-article:2047569pubmed:meshHeadingpubmed-meshheading:2047569-...lld:pubmed
pubmed-article:2047569pubmed:meshHeadingpubmed-meshheading:2047569-...lld:pubmed
pubmed-article:2047569pubmed:meshHeadingpubmed-meshheading:2047569-...lld:pubmed
pubmed-article:2047569pubmed:meshHeadingpubmed-meshheading:2047569-...lld:pubmed
pubmed-article:2047569pubmed:meshHeadingpubmed-meshheading:2047569-...lld:pubmed
pubmed-article:2047569pubmed:year1991lld:pubmed
pubmed-article:2047569pubmed:articleTitleEffect of cepharanthine on doxorubicin cytotoxicity in P388 murine leukemia cells in vitro and in vivo.lld:pubmed
pubmed-article:2047569pubmed:affiliationDepartment of Pharmacology and Toxicology, Cancer Research Institute, Tohoku College of Pharmacy, Sendai, Japan.lld:pubmed
pubmed-article:2047569pubmed:publicationTypeJournal Articlelld:pubmed